REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., trading under the ticker PAIC, filed a definitive proxy statement (DEF 14A) with the SEC on May 11, 2026, accession number 0001193125-26-215804. The filing signals an active shareholder vote is pending, consistent with a SPAC business combination requiring stockholder approval. Revelation Biosciences operates in the life sciences and biotechnology sector, positioning PAIC among the healthcare-focused SPAC transactions that have drawn continued investor scrutiny in recent years. The DEF 14A submission reflects the formal stage of the de-SPAC process, ahead of any final vote. Sign up for a SpacDesk account to access the full filing breakdown, vote timelines, and real-time deal intelligence on PAIC and every active SPAC transaction.